2nd Respiratory Drugs Summit: Formulation & Drug Delivery

Takeda has been putting patients first for more than two centuries. We are a global, science-driven biopharmaceutical leader with headquarters in Japan and the U.S., guided by our Patient-Trust-Reputation-Business philosophy. This perspective represents who we are and guides how we act, helping us make decisions we can be proud of today and in the future.

As a member of our team, you’ll help deliver on our mission to strive for better health and a brighter future for people worldwide through leading innovation in medicine. It’s a responsibility that motivates and inspires us all.

You’ll find your own professional inspiration at Takeda, in the area that suits your interests and skills. Whether that’s R&D, Oncology, Corporate, Manufacturing, Quality, or another business unit, wherever you find yourself at Takeda, you’ll enjoy a meaningful career that’s making a positive impact on patients, people and the planet.

Aerogen improves the lives of vulnerable patients worldwide through superior aerosol drug delivery – ultimately transforming respiratory care. Dedicated to scientific excellence, Aerogen innovates based on what’s best for the patient and care team and is focused on:

– Bringing peace of mind to patients and loved ones by safely and rapidly delivering more medication to the lungs, increasing speed of recovery.

– Helping care providers more effectively treat patients, while also empowering them to focus on strategic tasks and reducing their risk of exposure to patient-generated infectious aerosols.

– Assisting health systems to improve patient satisfaction and outcomes, reduce admissions, increase hospital discharges and decrease length of stay by more safely and effectively getting medications to patients.

– Helping to drive the next generation of effective and safer aerosol medication delivery for the treatment of many of the world’s most difficult health issues, in partnership with pharmaceutical companies.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Clear and confident health care decisions begin with questions. At Labcorp, They’re constantly in pursuit of answers.

With unparalleled diagnostics and drug development capabilities, they accelerate innovation and provide insight to improve health and improve lives. Whether they’re a patient, provider, researcher or in the pharmaceutical industry, they’re here for you. More than 70,000 employees strong, they serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020.

OnResp partners with Pharma, Biotech, Medical device companies and research institutes to expedite dry powder and soft mist inhalation solutions, targeting the pulmonary and nasal delivery of biologics and small molecules. From concept to lab and production, in research or GMP environment, across drug product development.

The Research Center for Pharmaceutical Engineering (RCPE) is a global leader in pharmaceutical engineering sciences. We help our partners to create and manufacture advanced medicines for patients around the world, through optimising products and processes.

Leveraging the expertise of our unique multidisciplinary team and our state-of-the-art capabilities in modeling, material science, process design, quality assurance and control, we redefine current thinking in the field of healthcare offering cutting-edge, scientific solutions tailored to customer needs.

RCPE’s services encompass the entire value chain of pharmaceutical product development: continuous API synthesis, advanced formulations, next-generation manufacturing, and also device design and optimization.

As a non-profit, private company owned by Graz University of Technology (65%), University of Graz (20%) and Joanneum Research GmbH (15%), we link outstanding science, application and industry in a business-oriented approach.

The Royal College of Surgeons in Ireland (RCSI) is a medical professional and educational institution, which is also known as RCSI University of Medicine and Health Sciences, Ireland’s first private university. It was established in 1784 as the national body for the surgical branch of medicine in Ireland, with a role in supervision of training, and as of 2021 provides a broad range of medical education in multiple countries.

RCSI’s main campus is situated on St. Stephen’s Green and York Street in central Dublin and incorporates schools of medicine, pharmacy, physiotherapy and nursing. It offers undergraduate and postgraduate education in a number of healthcare fields.

The RCSI achieved Ireland’s highest position in the Times Higher Education (THE) University Impact Rankings 2021, coming joint second in the world for ‘Good Health and Wellbeing’ from a total of 871 institutions. THE University Impact Rankings recognise universities around the world for their social and economic impact based on the United Nations’ 17 Sustainable Development Goals (SDGs).

DFE Pharma is a global leader in pharmaceutical excipient solutions. We develop, produce and supply the highest quality functional excipients for use in the pharmaceutical, biopharmaceutical and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients play an essential role as fillers, binders, disintegrants, and in stabilizing active ingredients for release in a predictable and effective manner into the patient’s system. With over a century of experience and over 400+ people worldwide in over 100 countries serving over 5,000 customers, DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives. We are driven by our purpose your medicines, our solutions. Moving to a healthier world.

Trinity College Dublin is recognised internationally as Ireland’s premier university and is ranked joint 98th position in the world (QS World University Rankings (2023). In the Times Higher Education World University Rankings, Trinity is ranked 164th in the world.

Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, and you can count on us to keep working tirelessly to make that future a reality for patients everywhere, by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.

We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Arterial Hypertension.

ICONOVO AB is developing proprietary inhalation products for licensing. We have long experience and track record in the development of dry powder inhalers and offer a comprehensive range of devices to our clients. Our selection of device concepts for dry powder inhalation include a reservoir inhaler, a pre-metered inhaler, a capsule based inhaler and a single dose disposable inhaler. We can also provide formulation development, performance testing, documentation and a complete supply-chain.

MEGGLE is a pioneer in co-processing technologies. Through co-processing, MEGGLE developed highly functional excipients possessing unique qualities for directly compressible immediate and sustained release pharmaceutical solid dosage forms.

MEGGLE Business Unit Excipients serves the pharmaceutical and nutraceutical markets with a global network of offices and authorized distribution partners. Supporting supply chain security with manufacturing facilities in Europe and North America. Our broad portfolio of products, multiple manufacturing locations, technical centers in major markets, and innovative technologies, make MEGGLE the preferred supplier and valued partner for our customers.

MEGGLE Products:

• Lactose monohydrate
• Anhydrous Lactose
• Co-Processed Excipients
• Lactose for Inhalation
• Lactose for lyophilization and parenteral applications
• Tailor-made lactose products

MEGGLE Services:

• Spray drying
• Co-Processing
• Agglomeration
• Product Customization

The University of Hertfordshire (UH) is a public university in Hertfordshire, United Kingdom. The university is based largely in Hatfield, Hertfordshire. Its antecedent institution, Hatfield Technical College, was founded in 1948 and was identified as one of 25 Colleges of Technology in the United Kingdom in 1959.

Based in Diepenbeek, Belgium, Softhale N.V. is a pharmaceutical company specializing in the development of inhalable respiratory products for the medical treatment of various indications including, for example, Asthma or COPD. In Softhale’s office and labs, the focus lies on product development, formulation development, and analytical capabilities. The team is led by international industry experts (hardware, formulation, analytics, manufacturing, commercialization) and supported by external (inter-)national services providers.

The Company’s proprietary, propellant-free, purely mechanical device delivers medication to the lungs more effectively than other types of inhalers and is poised to change the treatment paradigm in large markets including asthma and COPD. Softhale’s products to be used for pharmaceutical development and approval processes are innovative as well as cost-optimized.